Part Details | USP CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES
6505-01-099-4064
Alternate Parts: NDC00555003302, NDC00555-0033-02, NDC00591078601, NDC00591-0786-01, NDC51079037521, NDC51079-0375-21, NDC51079037520, NDC51079-0375-20, NDC49884095901, NDC49884-0959-01, NDC00187375110, NDC00187-3751-10, 6505-01-099-4064, 01-099-4064, 6505010994064, 010994064
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | AUG 19, 1980 | 01-099-4064 | 30795 ( CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-099-4064
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00555-0033-02 | 56490 | BARR LABORATORIES, INC. |
| NDC00591-0786-01 | 62051 | DANBURY PHARMACAL INC |
| NDC51079-0375-21 | 65751 | MYLAN INSTITUTIONAL INC. |
| NDC51079-0375-20 | 65751 | MYLAN INSTITUTIONAL INC. |
| NDC49884-0959-01 | 0VZ14 | PAR PHARMACEUTICAL, INC.DBA PAR PHARMACEUTICAL |
| NDC00187-3751-10 | 3AWU3 | VALEANT PHARMACEUTICALSINTERNATIONAL CORPORATION |
Technical Data | NSN 6505-01-099-4064
| Characteristic | Specifications |
|---|---|
| CAPSULE TYPE | HARD |
| CAPSULE CONTENT FORM | POWDER |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB10.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE |
| PRIMARY CONTAINER TYPE | STRIP, ROLL |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 25.000 |
| TOTAL PRIMARY CONTAINER QUANTITY | 4 |
| SECONDARY CONTAINER TYPE | BOX |
| PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 1 STRIP, ROLL |
| TOTAL SECONDARY CONTAINER QUANTITY | 4 |
| FEATURES PROVIDED | INDIVIDUALLY SEALED |
| SUPPLEMENTARY FEATURES | CONSISTS OF 4 BOXES EA CONTAINING 25 CAPSULES |
| SPECIAL FEATURES | REVERSE-NUMBERED ROLLED STRIPS |
| PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 10MG I.S. 100S |